Table 5.
Overall assessment of the quality of anti-tuberculosis drugs, Almaty, Kazakhstan, 2014 (n = 14)
| Generic name | Manufacturer | Batch number | Physical inspection |
Disintegration test |
TLC | Assessment status |
|---|---|---|---|---|---|---|
| Isoniazid | PhC Romat | 010113, 020113 | —* | +† | + | Failed |
| 290213 | ||||||
| 190213 | + | + | + | Passed | ||
| Rifampicin | PhC Romat | 50212, 30113, 30212, | — | + | — | Failed |
| 401212, 20113, 300613, 340913, | + | + | — | Failed | ||
| 20112, 220513, 361212 | — | + | + | Failed | ||
| Ethambutol | Macleods | FEL 105A | + | — | + | Failed |
| FEL 107A, FEL 108A | — | — | + | Failed | ||
| Ethambutol | Lupin | BL10018 | + | — | — | Failed |
| Rifampicin | Brinsalov-A | 170413, 40113 110213, 591214 | Not performed for liquid forms | + | Passed | |
| Pyrazinamide | Lupin | DN20021, DN20022 | — | + | + | Failed |
| DN10026, DN10036 | + | + | + | Passed | ||
| DN10027, DN20028 DN20010A | ||||||
| Ethionamide | Lupin | CH 20002 A | + | — | + | Failed |
| Prothionamide | Lupin | A300429, A300438 | + | + | + | Passed |
| A300439, A300346 DN28030 | ||||||
| Cycloserine | Global Pharm | 30113, 521212 | + | + | + | Passed |
| 220513,190513 | ||||||
| Kanamycin | Santo | 20313 | Not performed for liquid forms | — | Failed | |
| 10113, 10212 | + | Passed | ||||
| Ofloxacin | Global Pharm | 40112 | + | — | + | Failed |
| Levofloxacin | Chimfarm | 160712, 70512 | + | + | + | Passed |
| Moxifloxacin | MSN Laboratories | 41302200, 41301212 | + | + | + | Passed |
| Amoxicillin, clavulanic acid | Unichem Laboratories | BMVM12051 BMVM13020 BMVM13005 | + | + | + | Passed |
*
— Failed testing.
†
+ Passed testing.
TLC = thin-layer chromatography.